Intelligence Β· Clinical Pipeline
Phase I Pipeline Programs
First-in-human and early clinical safety studies in Phase I.
- Programs
- 4,713
Quick answer
NovaPharmaNews tracks 4,713 phase i pharmaceutical pipeline programs from ClinicalTrials.gov. First-in-human and early clinical safety studies in Phase I.
Top sponsors
- BRIGHT MINDS BIOSCIENCES 327 programs
- Takeda 276 programs
- Anaxis Pharma 204 programs
- Chinese Academy of 190 programs
- United Therapeutics Europe 184 programs
- Teva Pharma 154 programs
- First People's Hospital 149 programs
- Regeneron UK 126 programs
- Boehringer Ingelheim 94 programs
- Sunshine Guojian Pharmaceutical 85 programs
- Lakefront Biotherapeutics NV 62 programs
- HOFFMANN-LA ROCHE 58 programs
-
NX-5948
Nurix Therapeutics
Healthy Volunteer
2 trials -
NX210c
BRIGHT MINDS BIOSCIENCES INC.
Healthy Elderly
1 trial -
NXP800 in subjects with Ovarian Cancer
Lacuna Pharma Pty Ltd
Platinum-resistant, ARID1a-mutated ovarian, fallopian tube and primary peritoneal carcinoma
1 trial -
NY-ESO-1οΌTCR Affinity Enhancing Specific T cell TherapyοΌ
Chongqing Precision Biotech Co., Ltd
Bone Sarcoma
1 trial -
Nafamostat Mesilate
BRIGHT MINDS BIOSCIENCES INC.
Pharmacokinetics
1 trial -
Nalbuphine ER
Trevi Therapeutics
Hepatic Impairment
1 trial -
Nalbuphine HCl solution
Trevi Therapeutics
Nalbuphine
1 trial -
Nalmefene
BRIGHT MINDS BIOSCIENCES INC.
Opioid-Related Disorders
1 trial -
Naloxone
BRIGHT MINDS BIOSCIENCES INC.
Opioid-use Disorder
1 trial -
Naloxone
BRIGHT MINDS BIOSCIENCES INC.
Drug Overdose
1 trial -
Naloxone Hydrochloride
BRIGHT MINDS BIOSCIENCES INC.
Opioid-use Disorder
1 trial -
Naltrexone and Bupropion SR
BRIGHT MINDS BIOSCIENCES INC.
Methamphetamine Dependence
1 trial -
Naltrexone implant, 14.4 grams
BRIGHT MINDS BIOSCIENCES INC.
Opioid Use Disorder
1 trial -
Nanosensor
United Therapeutics Europe Ltd
MItochondrial Myopathies
1 trial -
Narcan 40 MG/ML Nasal Spray
BRIGHT MINDS BIOSCIENCES INC.
Opioid Induced Respiratory Depression
1 trial -
NatrunixTM
XBiotech Germany GmbH
Pharmacokinetics
1 trial -
Navitoclax
AbbVie
Acute Lymphoblastic Leukemia (ALL)
1 trial -
Nemonoxacin
Jian Li
Kidney Dysfunction
1 trial -
NeoTISLEGA - A phase Ib trial evaluating the safety and activity of neoadjuvant combination of tislelizumab plus FLOT for resectable esophagogastric adenocarcinoma
The George Institute
resectable esophagogastric adenocarcinoma
1 trial -
Neoadjuvant chemotherapy
Hospital Authority, Hong Kong
Squamous Cell Carcinoma of Oral Cavity
1 trial -
Neratinib
PUMA BIOTECHNOLOGY, INC.
Advanced Malignant Solid Tumors
3 trials -
Neratinib
PUMA BIOTECHNOLOGY, INC.
Neoplasms
1 trial -
Neratinib
PUMA BIOTECHNOLOGY, INC.
Healthy Subjects
3 trials -
Neratinib (HKI-272)
PUMA BIOTECHNOLOGY, INC.
Hepatic Insufficiency
1 trial -
Neratinib 160 mg
PUMA BIOTECHNOLOGY, INC.
Advanced Solid Tumor
1 trial -
Neratinib Pill
PUMA BIOTECHNOLOGY, INC.
Gastric Cancer
1 trial -
NeuroRegen scaffold with BMMCs or MSCs transplantation
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Spinal Cord Injury
1 trial -
Nevirapine
Teva Pharma GmbH
HIV-1
1 trial -
New formulation
GlaxoSmithKline
Herpes Labialis
1 trial -
Nezulcitinib (TD-0903) Dose A
Theravance Biopharma Ireland Umited
Acute Lung Injury (ALI) Due to Coronavirus Disease-2019 (COVID-19)
1 trial -
Nicorette Extra Mint 2 mg Gum
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Tobacco Dependence
1 trial -
Nicotine
BRIGHT MINDS BIOSCIENCES INC.
Nicotine Dependence
1 trial -
Nicotine
BRIGHT MINDS BIOSCIENCES INC.
Smoking Addiction
1 trial -
Nicotine (Pharmaceutical Productions Inc.)
BRIGHT MINDS BIOSCIENCES INC.
Nicotine Pharmacokinetic Study
1 trial -
Nicotine Patch
BRIGHT MINDS BIOSCIENCES INC.
Smoking
1 trial -
Nicotine Pouches
BRIGHT MINDS BIOSCIENCES INC.
Nicotine Pouch Self-Administration
1 trial -
Nicotine Replacement Therapy
BRIGHT MINDS BIOSCIENCES INC.
Tobacco Use Disorder
1 trial -
Nicotine gum (C)
Century Therapeutics
Tobacco Use
2 trials -
Nicotine nasal spray 0.5 mg
BRIGHT MINDS BIOSCIENCES INC.
Adverse Childhood Experiences
1 trial -
Nicotine patch
BRIGHT MINDS BIOSCIENCES INC.
Nicotine Addiction
1 trial -
Nicotine polacrilex
BRIGHT MINDS BIOSCIENCES INC.
Depressive Disorder
1 trial -
Nicotine saline infusion 0.00mcg/kg/s
BRIGHT MINDS BIOSCIENCES INC.
Nicotine Dependence
1 trial -
Nicotrol
BRIGHT MINDS BIOSCIENCES INC.
Tobacco Use Disorder
1 trial -
Nifedipine 60 MG Extended Release Oral Tablet
BRIGHT MINDS BIOSCIENCES INC.
Healthy Volunteers
1 trial -
Nimotuzumab
Biotech Pharmaceutical Co.,
Solid Tumors
1 trial -
Nimotuzumab and chemotherapy
Biotech Pharmaceutical Co.,
Non-small Cell Lung Cancer
1 trial -
Niraparib
Takeda
Advanced Solid Tumors
1 trial -
Nivolumab
Nektar Therapeutics UK Limited
Renal Cell Carcinoma
1 trial
Frequently asked questions
How many Phase I pipeline programs are in the directory?
4,713 published programs match this development stage in our ClinicalTrials.gov index.
What defines this pipeline stage?
Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.
Data attribution: Data sources Β· All pipeline programs